Back to Journals » Neuropsychiatric Disease and Treatment » Volume 14

Factors impacting the efficacy of venlafaxine extended release 75–225 mg/day in patients with major depressive disorder: exploratory post hoc subgroup analyses of a randomized, double-blind, placebo-controlled study in Japan

Total article views   Abstract views HTML views PDF downloads Totals
3,786 Dovepress* 3,434 237+ 332 3,671
PubMed Central* 0 115 40 115
Totals 3,434 352 372 3,786
*Since 16 May 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
10 1 0 0 4 5

View citations on PubMed Central and Google Scholar